RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CAVANNA L
Collezione ASL Biella

Items : 10

Modified FOLFOXIRI plus cetuximab and avelumab as initial therapy in RAS wild-type unresectable metastatic colorectal cancer: Results of the phase II AVETRIC trial by GONO in Annals of Oncology

2023
ASL Biella

Conca V; Antoniotti C; Bergamo F; Pietrantonio F; Rossini D; Scartozzi M; Perissinotto E; Leone A; Pusceddu V; Borelli B; Cavanna L; Latiano T; Santini D; Masi G; Salvatore L; Frassineti G; Leone F; Tamberi S; Boni L; Cremolini C;

From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy. in Cancers / Cancers (Basel). 2020 May 22;12(5):1330. doi: 10.3390/cancers12051330.

2020
ASL Biella

Scartozzi M; Labianca R; Cascinu S; Puzzoni M; Libertini M; Zagonel V; Codecà C; Germano D; Lai E; Sozzi P; Pusceddu V; Zampino MG; Demurtas L; Pella N; Casagrande M; Cavanna L; Rosati G; Zaniboni A; Ferrari D; Lonardi S; Zizzi A; Daniele B; Ziranu P; Giampieri R;

Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Jun;132:17-23. doi: 10.1016/j.ejca.2020.03.024. Epub 2020 Apr 6.

2020
ASL Cuneo 2
ASL Biella

Grossi F; Scanni A; Blasi L; Zamagni C; Pinotti G; Ortega C; Montesarchio V; Giordano M; Fiorentini G; Cavanna L; Clerico M; Fioretto L; Daniele B; Indini A; Aschele C;

Oral prolonged-release Oxycodone-Naloxone: analgesic response, safety profile, and factors influencing the response in advanced cancer patients. in Pain practice : the official journal of World Institute of Pain / Pain Pract. 2019 Mar 27. doi: 10.1111/papr.12784.

2019
ASL Biella

Corsi N; Marabese M; Pacchioni M; Crispino C; Bortolussi R; Clerico M; Mistretta R; Dauri M; Cartoni C; Di Marco P; De Santis S; Schiavon S; Cavanna L; Azzarello G; Roberto A; Rulli E; Legramandi L; Iorno V; Corli O;

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis. in The oncologist / Oncologist. 2019 Mar;24(3):385-393. doi: 10.1634/theoncologist.2018-0442. Epub 2019 Jan 3.

2019
ASL Biella

Di Bartolomeo M; Galli F; Dotti KF; Antista M; Aglietta M; Cinieri S; Faedi M; Gori S; Cavanna L; Ciarlo A; Barni S; Leonardi F; Giordani P; Clerico M; Adamo V; Tamburini E; Re GL; Ferrario S; Buonadonna A; Tronconi MC; Pavesi L; Frassineti GL; Nicolini M; Rosati G; Labianca RF; Bidoli P; Ferrari D; Banzi M; Damiani A; et alii...

First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial. in British journal of cancer / Br J Cancer. 2017 Oct 10;117(8):1099-1104. doi: 10.1038/bjc.2017.234. Epub 2017 Sep 19.

2017
ASL Biella

Cascinu S; Labianca R; Codecà C; Libertini M; Zagonel V; Sozzi P; Germano D; Zampino MG; Pella N; Rosati G; Cavanna L; Zaniboni A; Lonardi S; Ferrari D; Daniele B; Puzzoni M; Giampieri R; Scartozzi M;

Erratum to "Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life" [Eur J Cancer 69 (2016) 110-118]. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2017 Feb;72:272-273. doi: 10.1016/j.ejca.2016.11.024. Epub 2016 Dec 24.

2017
ASL Biella
AOU Città della Salute di Torino
ASL Alessandria

Casadei Gardini A; Monti M; Nanni O; Pedrazzoli P; Frassineti GL; Galiano A; Alquati S; Quadrini S; Zagonel V; Cavanna L; Ferrari D; Giacobino A; Luzzani M; Luchena G; Fioretto L; Cattaneo MT; Bortolussi R; Garetto F; Biasini C; Codecà C; Broglia CM; Sansoni E; Scarpi E; Schiavon S; Dall'Agata M; Maltoni M;

Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2016 Dec;69:110-118. doi: 10.1016/j.ejca.2016.10.004. Epub 2016 Nov 4.

2016
ASL Biella
AOU Città della Salute di Torino

Monti M; Nanni O; Casadei Gardini A; Pedrazzoli P; Frassineti GL; Galiano A; Ferrari D; Cavanna L; Zagonel V; Quadrini S; Luchena G; Alquati S; Luzzani M; Cattaneo MT; Giacobino A; Fioretto L; Bortolussi R; Garetto F; Sansoni E; Broglia CM; Codecà C; Biasini C; Schiavon S; Scarpi E; Dall'Agata M; Maltoni M;

First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: Final results of the Italian Research Group for Digestive Tract Cancer (GISCAD) CENTRAL (ColorEctalvastiNTRiAlLdh) and SENTRAL (Serum angiogenesis-cENTRAL) analysis in Journal of Clinical Oncology

2016
ASL Biella

Scartozzi M; Giampieri R; Daniele B; Ferrari D; Lonardi S; Zaniboni A; Cavanna L; Rosati G; Pella N; Zampino MG; Sozzi P; Casula L; Cozzi L; Germano D; Puzzoni M; Loretelli C; Zagonel V; Labianca R; Frontini L; Cascinu S;

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer in Annals of Oncology

2014
ASL Biella
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 2

Bajetta E; Floriani I; Di Bartolomeo M; Labianca R; Falcone A; Di Costanzo F; Comella G; Amadori D; Pinto C; Carlomagno C; Nitti D; Daniele B; Mini E; Poli D; Santoro A; Mosconi S; Casaretti R; Boni C; Pinotti G; Bidoli P; Landi L; Rosati G; Ravaioli A; Cantore M; Di Fabio F; Aitini E; Marchet A; Rulli E; Cropalato Di Tullio M; et alii...